AMGEN INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Amgen Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2024.
  • Amgen Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.71B, a 108% decline year-over-year.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21B.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$4.04B, a 51.2% increase from 2021.
  • Amgen Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$8.27B, a 69.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.71B -$23.2B -108% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q1 2023 $21.5B +$25B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q1 2022 -$3.51B -$1.58B -81.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q1 2021 -$1.94B -$1.69B -663% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 -$254M +$4.73B +94.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q1 2019 -$4.99B +$6.71B +57.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 -$11.7B -$9.58B -454% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 -$2.11B -$3.34B -272% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q1 2016 $1.23B +$2.62B Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q1 2015 -$1.4B -$902M -182% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q1 2014 -$495M +$3.09B +86.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q1 2013 -$3.59B -$2.22B -163% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q1 2012 -$1.37B +$1.13B +45.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q1 2011 -$2.5B -$1.92B -333% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q1 2010 -$576M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.